Under PARs current guidance it’s slated for late 2024…002 and 003 are big trials - it’s easy to envisage delays in both trials, and further delays in FDA approval, despite fast track. Overlay that with the historic pattern of PAR to grossly underestimate their time estimates, and 2027 is a distinct (although admittedly v.conservative) possibility
Ann: Trading Halt, page-250
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 123000 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 21502 | 1 |
View Market Depth
| Last trade - 09.42am 21/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
Day chart unavailable